VasculazeMAX treats visible veins, spider veins, port-wine stains, telangiectasias, and angiomas on the arms, thighs, and lower legs, giving your skin a clearer, healthier appearance.
Workstation: OPTIMAS MAX
FORMA / PLUS
Forma and Plus are innovative thermal technologies that deploy targeted bipolar RF energy to dermal and subdermal zones. Equipped with intelligent epidermal monitoring, they provide non-invasive, pain-free procedures that are safe and efficacious. Built-in auto-adjusting RF thermistors read skin temperature 1000 times/second, allowing the treatment to reach clinically proven optimal temperatures. Forma is for smaller tissue areas, and Plus is for larger areas.
DIOLAZEXL MAX
DiolazeXL MAX has an 810 nm Diode laser for highly efficacious, fast hair removal treatments. All procedures are comfortable and pain-free, even on coarse and stubborn hair.
LUMECCA PEAK
Lumecca Peak intense pulsed light (IPL), engineered with 25% more optical power and shorter pulse duration, delivers faster results to address vascular and pigmented lesions, superficial vessels, and photodamage on light and dark skin tones. The custom Xenon flash lamp, large sapphire cooling tip, and high pulse repetition rate reduce treatment times, delivering photorejuvenation in fewer treatments than standard IPLs.
FUSION LIGHT / FUSION DARK
Fusion Light and Fusion Dark provide the best-in-class wavelengths, 755 nm Alexandrite, 810 nm Diode, and 1064 nm Nd:YAG, to meet patient demand for the number one procedure in the world: hair removal.
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
IRVINE, Calif., July 17, 2024 /PRNewswire/ — InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, is pleased to announce an additional FDA 510(k) clearance for the Morpheus8 technology. Morpheus8 is the first and only fractional radiofrequency (FRF) microneedling technology cleared for contraction of soft tissue.
The U.S. Food and Drug Administration (FDA) has cleared the use of the Morpheus8 Applicators for the delivery of fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is needed. This FDA action expands Morpheus8’s existing FDA clearance, emphasizing the versatility of the technology for physicians and patients.
Coinciding with this clearance is the launch of the new IgniteRF and OptimasMAX platforms, which include the Morpheus8 family of handpieces. The modular portfolio of tips, including Prime 12 pin, Morpheus8 24 pin, Resurfacing 24 pin, and Morpheus8 40 pin, makes this technology a versatile solution delivering exceptional patient results. The IgniteRF and OptimasMAX platforms support 14 technologies, including minimally invasive radiofrequency assisted soft tissue coagulation and contraction, non-invasive thermal radiofrequency, intense pulsed light skin treatments, and multi-wavelength hair reduction.
“InMode is dedicated to investing in R&D so we can provide medical professionals with continued advancements they need to deliver the highest quality of care and best-in-class results,” said Moshe Mizrahy, CEO of InMode. “The new indication for soft tissue contraction enhances the product’s intended use, helping Morpheus8 practitioners expand their patient base.”
Since inception, Morpheus8 has gained widespread global brand awareness, with more than 2.5 million procedures performed worldwide, and an average of 8.2 treatments performed every minute. The Morpheus8 brand has become so popular that consumers and celebrities request it by name. It is a trusted procedure known for delivering both natural and striking results.
Find out more – Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
MORPHEUS8 burstdeep
Morpheus8 Burst Deep is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. With the ability to deliver both subdermal multi-level contraction and dermal contraction, Morpheus8 Burst Deep provides the deepest levels of targeted RF energy deposition available. Equipped with proprietary Burst and Scale technologies, Morpheus8 Burst Deep’s large 40-pin surface tip automatically deploys bipolar RF energy, in millisecond intervals, to multi-level treatment depths and energy levels in a single pulse.
MORPHEUS8 Burst
Morpheus8 Burst is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. Equipped with proprietary Scale and Burst functionalities, these innovative technologies automatically deploy bipolar RF to multi-level treatment depths and programmable energy levels in millisecond intervals with a single pulse. This range of functionality makes Morpheus8 Burst a versatile tool to safely and efficaciously meet patient demand for dermal contraction and subdermal adipose treatments.
